A method to assess efficacy of CAPD: preliminary results

Area of Science:

• Nephrology
• Renal Medicine
• Dialysis Therapy

Background:

• Adequacy of dialysis is crucial for patients on continuous peritoneal dialysis (CAPD).
• Objective assessment of CAPD efficacy is needed to optimize patient care.
• Current methods may not fully capture dialysis effectiveness.

Purpose of the Study:

• To introduce and validate an 'efficacy number' (EN) for objectively assessing CAPD adequacy.
• To compare the EN with existing parameters like the dialysate/plasma (D/P) ratio.
• To provide a tool for guiding adjustments to CAPD prescriptions.

Main Methods:

• Calculated an 'efficacy number' (EN) using creatinine (cr) data from peritoneal equilibration tests (PET).
• EN formula: [cr(D/P) x V24] / ACPPD, where cr(D/P) is the 4-hr dialysate/plasma creatinine ratio, V24 is 24-hr exchange volume, and ACPPD is adjusted creatinine production.
• Assessed EN in two groups of CAPD patients over 10 months: one with poor uremic parameters and one with good outcomes.

Main Results:

• Patients with poor clinical outcomes had a significantly lower EN (3.85 +/- 0.45 L/g creatinine/day) compared to well-dialyzed patients (6.07 +/- 0.40 L/g creatinine/day, p < 0.001).
• No significant differences were found between groups regarding demographics, dialysis duration, or baseline creatinine/BUN D/P ratios.
• The EN proved more informative than the D/P ratio alone in determining CAPD adequacy.

Conclusions:

• The 'efficacy number' (EN) is a valuable tool for objectively assessing continuous peritoneal dialysis (CAPD) adequacy.
• EN effectively differentiates between well-dialyzed and poorly dialyzed CAPD patients.
• A presented nomogram aids clinicians in modifying CAPD prescriptions based on EN values.